Purchases and Sales Made in Q1 2023 in Halozyme Therapeutics, Inc. (HALO)
This table provides information about the institutional ownership of Halozyme Therapeutics, Inc. (HALO) during Q1 2023. The information is specifically focused on institutions that hold shares of HALOZYME THERAPEUTICS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2023
Q1 2023
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-303K- 91.54% |
$9.95M - $16.9M
|
28K
$1.6M
|
|
|
May 08, 2023
Q1 2023
|
Braun Stacey Associates Inc
|
SELL
|
- |
-334K- 95.16% |
$11M - $18.6M
|
17K
$971K
|
|
|
May 15, 2023
Q1 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-337K- 61.09% |
$11.1M - $18.8M
|
214K
$12.2M
|
|
|
May 14, 2024
Q1 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-386K- 19.36% |
$12.7M - $21.5M
|
1.61M
$91.8M
|
|
|
May 11, 2023
Q1 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-386K- 19.36% |
$12.7M - $21.5M
|
1.61M
$91.8M
|
|
|
May 12, 2023
Q1 2023
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-528K- 49.64% |
$17.4M - $29.4M
|
536K
$30.6M
|
|
|
May 15, 2023
Q1 2023
|
Driehaus Capital Management LLC
Chicago, IL |
SELL
|
- |
-842K- 62.71% |
$27.7M - $46.9M
|
501K
$28.6M
|
|
|
May 02, 2023
Q1 2023
|
Victory Capital Management Inc
|
SELL
|
- |
-1.17M- 82.97% |
$38.6M - $65.4M
|
241K
$13.8M
|
|
|
May 12, 2023
Q1 2023
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-2.51M- 41.87% |
$82.6M - $140M
|
3.49M
$199M
|